Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Share-based Compensation (2018 - 2026)

Equillium (EQ) posted quarterly Share-based Compensation of $930000.0 for Q1 2026, up 49.76% year-over-year from $621000.0 in Q1 2025, and up 189.68% quarter-over-quarter from -$1.0 million in Q4 2025.

Analysis

Equillium (EQ) Share-based Compensation (2018 - 2026) Analysis & Trends

Equillium (EQ) has reported Share-based Compensation for 9 consecutive years, with $930000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Share-based Compensation rose 49.76% year-over-year to $930000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 60.72% YoY), while the FY2025 annual figure was $7.7 million, up 105.33% from the prior year.
  • Share-based Compensation advanced to $930000.0 in Q1 2026 per EQ's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $8.4 million in Q3 2025 and bottomed at -$3.7 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $991176.5 across 5 years, with a median of $952000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Share-based Compensation soared 6505.56% — and 2025, when it plunged 226.31%.
  • Equillium's Share-based Compensation stood at -$3.7 million in 2022, then surged by 128.0% to $1.0 million in 2023, then retreated by 21.51% to $821000.0 in 2024, then slumped by 226.31% to -$1.0 million in 2025, then jumped by 189.68% to $930000.0 in 2026.
  • Business Quant data shows EQ's Share-based Compensation at $930000.0 in Q1 2026, -$1.0 million in Q4 2025, and $8.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Equillium 249.33 Mn 249.33 Mn - 15.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.46 Mn
Mar 31, 2026 14.31 Mn
Dec 31, 2025 737,000.00
Sep 30, 2025 11.28 Mn
Jun 30, 2025 9.91 Mn
Mar 31, 2025 10.16 Mn
Dec 31, 2024 821,000.00
Sep 30, 2024 9.19 Mn
Jun 30, 2024 9.18 Mn
Mar 31, 2024 9.05 Mn
Dec 31, 2023 1.05 Mn
Sep 30, 2023 7.17 Mn
Jun 30, 2023 7.32 Mn
Mar 31, 2023 7.10 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 5.34 Mn
Jun 30, 2022 5.30 Mn
Mar 31, 2022 5.21 Mn
Dec 31, 2021 1.15 Mn
Sep 30, 2021 3.93 Mn